相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of age, comorbidity, and treatment characteristics on survival in older women with advanced high grade epithelial ovarian cancer
Adrianne Mallen et al.
GYNECOLOGIC ONCOLOGY (2021)
PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline
William P. Tew et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Fifteen-year survival of invasive epithelial ovarian cancer in women with BRCA1/2 mutations - the National Israeli Study of Ovarian Cancer
Ofer Lavie et al.
GYNECOLOGIC ONCOLOGY (2019)
Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation status
Joanne Kotsopoulos et al.
GYNECOLOGIC ONCOLOGY (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer
Francisco J. Candido-dos-Reis et al.
CLINICAL CANCER RESEARCH (2015)
Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands
P. M. L. H. Vencken et al.
ANNALS OF ONCOLOGY (2013)
Long-Term Ovarian Cancer Survival Associated With Mutation in BRCA1 or BRCA2
John R. McLaughlin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation-Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
Kathryn Alsop et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients
P. M. L. H. Vencken et al.
ANNALS OF ONCOLOGY (2011)
Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer
Ignace Vergote et al.
EUROPEAN JOURNAL OF CANCER (2011)
Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer
Da Yang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan et al.
NATURE REVIEWS CANCER (2011)
Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers
Anouk Pijpe et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
The genesis and evolution of high-grade serous ovarian cancer
David D. L. Bowtell
NATURE REVIEWS CANCER (2010)
BRCA1 and implications for response to chemotherapy in ovarian cancer
Jennifer E. Quinn et al.
GYNECOLOGIC ONCOLOGY (2009)
Does Paclitaxel-Carboplatin Chemotherapy in a Dose-Dense Regimen Enhance Survival of BRCA-Related Ovarian Cancer Patients?
Karin Leunen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
BRCAness Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated With BRCA1 and BRCA2 Mutations
David S. P. Tan et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: The national Israeli study of ovarian cancer
Angela Chetrit et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Meta-analysis of BRCA1 and BRCA2 penetrance
Sining Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Prediction of BRCA1/2 mutation status in patients with ovarian cancer from a hospital-based cohort
Catharina E. Jacobi et al.
GENETICS IN MEDICINE (2007)
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: A kin-cohort study in Ontario, Canada
Harvey A. Risch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Ovarian cancer
Nicoletta Colombo et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases
T Pal et al.
CANCER (2005)
One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations:: results of a prospective study in Southern Sweden
S Malander et al.
EUROPEAN JOURNAL OF CANCER (2004)
The role of BRCA1 in the cellular response to chemotherapy
RD Kennedy et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
MC King et al.
SCIENCE (2003)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Improved survival in women with BRCA-associated ovarian carcinoma
I Cass et al.
CANCER (2003)
BRCA I expression modulates chemosensitivity of BRCA I-defective HCC1937 human breast cancer cells
P Tassone et al.
BRITISH JOURNAL OF CANCER (2003)
分享论文
